Thursday 26 May 2016

  • Louis Roche lecture followed by Current challenges of opioids
    09:00-10:00 Neurotoxicity of Mercury: Two Fish Tales
    Louis Roche lecture
    Lecturer: Robert Hoffman, NYU School of Medicine, New York, USA
    10:00-10:20 Rethinking the nature of opiate addiction
    Lecturer: Anthony Daniels, City Hospital, Birmingham, UK
    10:20-10:40 Trends in opioid analgesic abuse and mortality in Europe
    Lecturer: Jody Green, Rocky Mountain Poison & Drug Center, Denver, USA
    10:40-11:25 Coffee and electronic posters
    E-POSTERS: 125; 249; 127 to 132 and 134 to 136 (see detailed at E-Posters tab)
    11:25-11:45 Abuse Deterrent Formulations of the opioids and their relation to heroin
    Lecturer: Richard Dart, Rocky Mountain Poison & Drug Center, Denver, USA
    11:45-12:05 Opioid overdose: mechanisms of toxicity and variability of presentation
    Lecturer: Bruno Mégarbane, Paris-Diderot University, Paris, France
    12:05-12:25 New opioids to limit toxicity: where are we going?
    Lecturer: Steven Ballet, Vrije Universiteit, Brussels, Belgium
    12:25-12:30 General discussion
    12:25-14:15 Lunch and posters

    Plenary lecture followed by Toxic aspects of ammunition
    14:15-15:00 Depleted uranium and health effects - a radiobiological view
    Lecturer: Matthias Port, Insitute of Radiobiology of the German Armed Forces, Munich, Germany
    15:00-15:20 Riot control agents
    Lecturer: Frederic Dorandeu, IRBA (French armed forces biomedical research institute), Brétigny-sur-Orge, France
    15:20-15:40 Medical aspects on dumped chemical warfare agents
    Lecturer: Horst Thiermann, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany
    15:40-16:10 Coffee and electronic posters
    E-POSTERS from 149 to 156 (see detailed at E-Posters tab)
    16:10-16:30 Toxicological aspects of fog/smoke/fumes
    Lecturer: Dirk Steinritz, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany
    16:30-16:50 Lead poisoning from intracorporeal bullets
    Lecturer: Michael Holland, Upstate New York Poison Center, New York, USA
  • Paracetamol mini symposium followed by Poster discussion session
    10:00-10:15 Clinical outcomes and predictive factors in “massive” paracetamol overdose (abstract no. 122)
    Lecturer: Daniel Marks, Guy's and St Thomas' Hospital, London, UK
    10:15-10:30 Pharmacokinetic modelling of a high dose acetylcysteine regimen based on the SNAP trial (abstract no. 123)
    Lecturer: Harry Thanacoody, National Poisons Information Service (Newcastle Unit), Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
    10:30-10:45 The standard treatment protocol is inadequate following overdose of extended release paracetamol: A pharmacokinetic and clinical analysis of 53 cases (abstract no. 124)
    Lecturer: Helene Salmonson, Swedish Poisons Information Centre, Stockholm, Sweden
    10:45-11:25 Coffee and electronic posters
    E-POSTERS: 125; 249; 127 to 132 and 134 to 136 (see detailed at E-Posters tab)
    11:25-12:30 Poster discussion session
    CME accreditation will not be requested for this session
    • 137. Massive paracetamol overdose: An observational study
    • 138. A multi-center, retrospective study to evaluate the safety and efficacy of a three-bag acetylcysteine dosing regimen compared to a two-bag acetylcysteine dosing regimen for the treatment of paracetamol overdose: The Danish Intravenous Acetylcysteine Study (DIVAS) 
    • 139. Metal-on-metal hip joint prostheses: A retrospective case series investigating association of systemic toxicity with serum cobalt and chromium concentrations
    • 140. Metal release from hip implant: Clinical experience with N-acetylcysteine as potential complexing agent in two cases
    • 141. Comparison of blood lead levels (BLL) in drug users, individuals under methadone maintenance therapy and healthy individuals 
    • 142. Human accidental poisoning in a rural and fishing occupational setting in Italy: A 5 year Poison Control Center study 
    • 143. Validation of a prediction rule for adverse cardiovascular events from drug overdose 
    • 144. Antagonizing the errors of history: Bedside experience with flumazenil 
    • 145. Effectiveness of correction of metabolic acidosis on intermittent versus continuous modes of hemodialysis in acute methanol poisoning
    • 146. Outbreak of facio-troncular dystonia in central Africa due to falsified diazepam containing haloperidol   
    • 147. To what extent does haloperidol-induced facio-troncular dystonic syndrome mimic infectious diseases? The Congo experience
    12:25-14:15 Lunch and posters

    Current challenges of opioids (continued)
    15:00-15:20 Opioid education programs and nasal naloxone rescue kits
    Lecturer: Arne Skulberg, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    15:20-15:35 Abuse of immediate release opioid analgesics as compared to extended release formulations in the US (abstract no. 148)
    Lecturer: Janetta Iwanicki, Rocky Mountain Poison and Drug Center, Denver, USA
    15:40-16:10 Coffee and electronic posters
    E-POSTERS from 149 to 156 (see detailed at E-Posters tab)
    16:10-16:55 Debate: Opioid dependence treatment: should substitution therapy be the management of choice?
    Timothy Wiegand (PRO), University of Rochester School of Medicine and Dentistry, Rochester, USA
    Karen Simone (CON), Northern New England Poison Center, Portland, USA